Sheri Dubey

6.3k citations

52 papers · 2.1k indexed · 1 hit paper · h-index 25

Co-authors: Danilo R. Casimiro John W. Shiver Michael Robertson Lisa Kierstead Devan V. Mehrotra Lawrence Corey Kara S. Cox M. Juliana McElrath
Topics: HIV Research and Treatment (18 papers)Viral Infections and Outbreaks Research (16 papers)Viral Infections and Vectors (13 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: The Lancet Nature Medicine PLoS ONE
Partner nations: United States Australia Japan

In The Last Decade

Sheri Dubey

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

2008 517 citations M. Juliana McElrath, Sheri Dubey et al. profile →

Peers

Countries citing papers authored by Sheri Dubey

Since Specialization

Citations

This map shows the geographic impact of Sheri Dubey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri Dubey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri Dubey more than expected).

Fields of papers citing papers by Sheri Dubey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheri Dubey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri Dubey. The network helps show where Sheri Dubey may publish in the future.

Co-authorship network of co-authors of Sheri Dubey

This figure shows the co-authorship network connecting the top 25 collaborators of Sheri Dubey. A scholar is included among the top collaborators of Sheri Dubey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheri Dubey. Sheri Dubey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates 2023 ·Cell Reports ·Bronwyn M. Gunn,Ryan P. McNamara,(unknown),(unknown),(unknown),Wenyu Guo,Jishnu Das,Avlant Nilsson,Amy C. Shurtleff,Sheri Dubey,M.J. Eichberg,Todd J. Suscovich,Erica Ollmann Saphire,Douglas A. Lauffenburger,Beth-Ann Coller,Jakub K. Simon,(unknown)	12
2	Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines 2022 ·Vaccines ·Beth-Ann Coller,William Lapps,(unknown),Samantha Bruno,M.J. Eichberg,(unknown),Kenneth Liu,Rosybel Drury,(unknown),(unknown),Thomas Armstrong,Jeffrey T. Blue,Lynne A. Isopi,Melissa E. Hughes,Susan M. VanRheenen,Jonathan Deutsch,Joan G. Tell,Sheri Dubey	6
3	Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach 2022 ·EBioMedicine ·(unknown),Nele Plock,Akshita Chawla,(unknown),Seth Robey,Kenny J. Watson,(unknown),Sheri Dubey,S. Y. Amy Cheung,Rik de Greef,Julie A. Stone,Jeffrey R. Sachs	9
4	Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials 2022 ·Vaccine ·Jakub K. Simon,Stephen B. Kennedy,Barbara E. Mahon,Sheri Dubey,Rebecca J. Grant-Klein,Ken Liu,Jonathan Hartzel,Beth-Ann Coller,(unknown),Mary E. Hanson,Rebecca F. Grais	11
5	Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men 2021 ·Contemporary Clinical Trials ·Anna R. Giuliano,Timothy Wilkin,Oliver Bautista,(unknown),(unknown),Sheri Dubey,Alain Luxembourg,Sonali Rawat,(unknown),Christine Velicer,(unknown),(unknown)	23
6	Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus – Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis 2020 ·Vaccine ·Joseph M. Antonello,Rebecca J. Grant-Klein,Richard Nichols,Stephen B. Kennedy,Sheri Dubey,Jakub K. Simon	9
7	Preclinical and clinical development of a dengue recombinant subunit vaccine 2015 ·Vaccine ·Susan B. Manoff,Sarah L. George,Andrew J. Bett,(unknown),Dhanasekaran Govindarajan,(unknown),(unknown),Sheri Dubey,Danilo R. Casimiro,David E. Clements,(unknown),(unknown),D E Parks,Beth-Ann Coller	51
8	Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination 2015 ·Frontiers in Immunology ·(unknown),Kara S. Cox,Sheri Dubey,Joseph M. Antonello,David L. Krah,Danilo R. Casimiro,Kalpit A. Vora	41
9	Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors 2013 ·Journal of Translational Medicine ·(unknown),Alberto Chiappori,Luigi Aurisicchio,Ansuman Bagchi,Jason Clark,Sheri Dubey,Arthur Fridman,Jesus C. Fabregas,John L. Marshall,Elisa Scarselli,Nicola La Monica,Gennaro Ciliberto,Alberto J. Montero	64
10	Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus 2012 ·Vaccine ·Tong‐Ming Fu,Dai Wang,Daniel C. Freed,Aimin Tang,Fengsheng Li,Xi He,Suzanne Cole,Sheri Dubey,Adam C. Finnefrock,Jan ter Meulen,John W. Shiver,Danilo R. Casimiro	57
11	Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study 2011 ·PLoS ONE ·Fusheng Li,Adam C. Finnefrock,Sheri Dubey,Bette Korber,James Szinger,Suzanne Cole,M. Juliana McElrath,John W. Shiver,Danilo R. Casimiro,Lawrence Corey,Steven G. Self	56
12	Synthesis and immunological activities of novel agonists of toll-like receptor 9 2010 ·Cellular Immunology ·Mary Struthers,Andrew J. Bett,Thomas Wısnıewskı,Sheri Dubey,Melissa Precopio,Weiwen Jiang,Zhenhua Sun,Hao Wang,Ireneusz Nowak,(unknown),Dong Soo Yu,Jimmy X. Tang,Ekambar R. Kandimalla,Sudhir Agrawal,Danilo R. Casimiro	13
13	Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans 2010 ·Vaccine ·Andrew J. Bett,Sheri Dubey,Devan V. Mehrotra,Liming Guan,Romnie Long,(unknown),Kelly Collins,(unknown),(unknown),Suzanne Cole,(unknown),Aimin Tang,Xiao Sun,Sanjay Gurunathan,Jim Tartaglia,Michael Robertson,John W. Shiver,Danilo R. Casimiro	21
14	Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality 2010 ·PLoS ONE ·Natalie A. Hutnick,Diane G. Carnathan,Sheri Dubey,Kara S. Cox,Lisa Kierstead,(unknown),Sarah J. Ratcliffe,Marcio O. Lasaro,Michael Robertson,Danilo R. Casimiro,Hildegund C.J. Ertl,Michael R. Betts	10
15	Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults 2010 ·AIDS Research and Human Retroviruses ·Ouzama Nicholson,(unknown),James G. Kublin,Xiao Sun,Erin Quirk,(unknown),Glenda Gray,Jean W. Pape,Michael Robertson,Devan V. Mehrotra,Steven G. Self,Katherine Turner,Jorge Sánchez,Punnee Pitisuttithum,Ann Duerr,Sheri Dubey,Lisa Kierstead,Danilo R. Casimiro,(unknown)	16
16	DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles 2008 ·Journal of Virology ·Kara S. Cox,James H. Clair,(unknown),Kara J. Sykes,Sheri Dubey,John W. Shiver,Michael Robertson,Danilo R. Casimiro	41
17	Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults 2008 ·AIDS Research and Human Retroviruses ·Clayton Harro,Michael Robertson,Michelle Lally,(unknown),Srilatha Edupuganti,Paul A. Goepfert,Mark J. Mulligan,Frances Priddy,Sheri Dubey,Lisa Kierstead,Xiao Sun,Danilo R. Casimiro,Mark J. DiNubile,John W. Shiver,Randi Y. Leavitt,Devan V. Mehrotra	46
18	Enhanced Rates and Magnitude of Immune Responses Detected against an HIV Vaccine: Effect of Using an Optimized Process for Isolating PBMC 2007 ·AIDS Research and Human Retroviruses ·Lisa Kierstead,Sheri Dubey,(unknown),Timothy W. Tobery,Robin Mogg,Violeta Fernández,Romnie Long,Liming Guan,(unknown),Kelly Collins,Kara J. Sykes,Devan V. Mehrotra,Narendra Chirmule,John W. Shiver,Danilo R. Casimiro	60
19	A Comparison of Standard Immunogenicity Assays for Monitoring HIV Type 1 gag-Specific T Cell Responses in Ad5 HIV Type 1 gag Vaccinated Human Subjects 2006 ·AIDS Research and Human Retroviruses ·Timothy W. Tobery,Sheri Dubey,(unknown),Daniel C. Freed,Kara S. Cox,Lin Jing,(unknown),Kara J. Sykes,Robin Mogg,Devan V. Mehrotra,Tong‐Ming Fu,Danilo R. Casimiro,John W. Shiver	26
20	Intracellular Staining for HIV-Specific IFN-γ Production: Statistical Analyses Establish Reproducibility and Criteria for Distinguishing Positive Responses 2003 ·Journal of Interferon & Cytokine Research ·Wendy L. Trigona,James H. Clair,Natasha Persaud,(unknown),(unknown),(unknown),Sheri Dubey,Lynda Tussey,Tong‐Ming Fu,John W. Shiver	18

About Sheri Dubey

Sheri Dubey is a scholar working on Virology, Modeling and Simulation and Infectious Diseases, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), Viral Infections and Outbreaks Research (16 papers) and Viral Infections and Vectors (13 papers). The work is most often cited by research in Virology (854 citations), Infectious Diseases (730 citations) and Immunology (831 citations). Sheri Dubey has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Danilo R. Casimiro, John W. Shiver, Michael Robertson, Lisa Kierstead, Devan V. Mehrotra, Lawrence Corey, Kara S. Cox, M. Juliana McElrath, Steven G. Self and Stephen C. De Rosa. Their work appears in journals such as The Lancet, Nature Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact